help button home button Am J Pathol PCR Enhanced. PCRboost from Biomatrica
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yeo, T. K.
Right arrow Articles by Toole, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yeo, T. K.
Right arrow Articles by Toole, B. P.

American Journal of Pathology, Vol 148, 1733-1740, Copyright © 1996 by American Society for Investigative Pathology


REGULAR ARTICLES

Increased hyaluronan at sites of attachment to mesentery by CD44- positive mouse ovarian and breast tumor cells

TK Yeo, JA Nagy, KT Yeo, HF Dvorak and BP Toole
Department of Anatomy and Cellular Biology, Tufts University School of Medicine, Boston, MA 02111, USA.

The mouse ovarian ascites tumor, MOT, and mammary ascites tumor, TA3/St, served as models to follow changes in hyaluronan levels during tumor growth, attachment, and invasion. Subsequent to introduction of tumor cells into the peritoneal cavity, hyaluronan accumulated intraperitoneally and at the initial sites of attachment of tumor cells and cell clumps to the mesenteric surface; the latter co-localized with sites of fibrin deposition as reported earlier. Subsequently, high levels of hyaluronan accumulated throughout the interior of the mesentery. Because neither tumor cell line synthesized substantial amounts of hyaluronan in culture, the large accumulations observed in the mesenteries and ascites fluid of tumor-bearing animals most likely resulted from increased synthesis and secretion by peritoneal-lining mesothelial cells and/or fibroblasts in response to stimulation by the tumor cells or their products. TA3/St tumor cells were universally positive for the hyaluronan receptor, CD44, whereas approximately 90% of MOT tumor cells were CD44-negative. However, the great majority of MOT or TA3/St cells that initially attached to the mesentery were strongly CD44 positive. We propose that hyaluronan-rich matrix is involved in tumor cell attachment to the mesentery possibly via interaction with tumor cell surface CD44.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Ricciardelli, D. L. Russell, M. P. Ween, K. Mayne, S. Suwiwat, S. Byers, V. R. Marshall, W. D. Tilley, and D. J. Horsfall
Formation of Hyaluronan- and Versican-rich Pericellular Matrix by Prostate Cancer Cells Promotes Cell Motility
J. Biol. Chem., April 6, 2007; 282(14): 10814 - 10825.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. I. Lopez, T. D. Camenisch, M. V. Stevens, B. J. Sands, J. McDonald, and J. A. Schroeder
CD44 Attenuates Metastatic Invasion during Breast Cancer Progression
Cancer Res., August 1, 2005; 65(15): 6755 - 6763.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Y. W. Bourguignon, E. Gilad, K. Rothman, and K. Peyrollier
Hyaluronan-CD44 Interaction with IQGAP1 Promotes Cdc42 and ERK Signaling, Leading to Actin Binding, Elk-1/Estrogen Receptor Transcriptional Activation, and Ovarian Cancer Progression
J. Biol. Chem., March 25, 2005; 280(12): 11961 - 11972.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ghatak, S. Misra, and B. P. Toole
Hyaluronan Constitutively Regulates ErbB2 Phosphorylation and Signaling Complex Formation in Carcinoma Cells
J. Biol. Chem., March 11, 2005; 280(10): 8875 - 8883.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Y. W. Bourguignon, P. A. Singleton, and F. Diedrich
Hyaluronan-CD44 Interaction with Rac1-dependent Protein Kinase N-{gamma} Promotes Phospholipase C{gamma}1 Activation, Ca2+ Signaling, and Cortactin-Cytoskeleton Function Leading to Keratinocyte Adhesion and Differentiation
J. Biol. Chem., July 9, 2004; 279(28): 29654 - 29669.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Sillanpaa, M. A. Anttila, K. Voutilainen, R. H. Tammi, M. I. Tammi, S. V. Saarikoski, and V.-M. Kosma
CD44 Expression Indicates Favorable Prognosis in Epithelial Ovarian Cancer
Clin. Cancer Res., November 1, 2003; 9(14): 5318 - 5324.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xu and Q. Yu
E-cadherin Negatively Regulates CD44-Hyaluronan Interaction and CD44-mediated Tumor Invasion and Branching Morphogenesis
J. Biol. Chem., February 28, 2003; 278(10): 8661 - 8668.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Y. W. Bourguignon, P. A. Singleton, H. Zhu, and B. Zhou
Hyaluronan Promotes Signaling Interaction between CD44 and the Transforming Growth Factor beta Receptor I in Metastatic Breast Tumor Cells
J. Biol. Chem., October 11, 2002; 277(42): 39703 - 39712.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ghatak, S. Misra, and B. P. Toole
Hyaluronan Oligosaccharides Inhibit Anchorage-independent Growth of Tumor Cells by Suppressing the Phosphoinositide 3-Kinase/Akt Cell Survival Pathway
J. Biol. Chem., October 4, 2002; 277(41): 38013 - 38020.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. M. Peterson, Q. Yu, I. Stamenkovic, and B. P. Toole
Perturbation of Hyaluronan Interactions by Soluble CD44 Inhibits Growth of Murine Mammary Carcinoma Cells in Ascites
Am. J. Pathol., June 1, 2000; 156(6): 2159 - 2167.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Auvinen, R. Tammi, J. Parkkinen, M. Tammi, U. Agren, R. Johansson, P. Hirvikoski, M. Eskelinen, and V.-M. Kosma
Hyaluronan in Peritumoral Stroma and Malignant Cells Associates with Breast Cancer Spreading and Predicts Survival
Am. J. Pathol., February 1, 2000; 156(2): 529 - 536.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. A. Anttila, R. H. Tammi, M. I. Tammi, K. J. Syrjänen, S. V. Saarikoski, and V.-M. Kosma
High Levels of Stromal Hyaluronan Predict Poor Disease Outcome in Epithelial Ovarian Cancer
Cancer Res., January 1, 2000; 60(1): 150 - 155.
[Abstract] [Full Text]


Home page
Mol. Biol. CellHome page
K. Maaser, K. Wolf, C. E. Klein, B. Niggemann, K. S. Zänker, E.-B. Bröcker, and P. Friedl
Functional Hierarchy of Simultaneously Expressed Adhesion Receptors: Integrin alpha 2beta 1 but Not CD44 Mediates MV3 Melanoma Cell Migration and Matrix Reorganization within Three-dimensional Hyaluronan-containing Collagen Matrices
Mol. Biol. Cell, October 1, 1999; 10(10): 3067 - 3079.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
S. Kayastha, A. N., F. M., S. Piver, J. Mukkamalla, M. Romero-Guittierez, and B. A. Werness
Expression of the Hyaluronan Receptor, CD44S, in Epithelial Ovarian Cancer Is an Independent Predictor of Survival
Clin. Cancer Res., May 1, 1999; 5(5): 1073 - 1076.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Y. W. Bourguignon, H. Zhu, L. Shao, and Y.-W. Chen
CD44 Interaction with c-Src Kinase Promotes Cortactin-mediated Cytoskeleton Function and Hyaluronic Acid-dependent Ovarian Tumor Cell Migration
J. Biol. Chem., March 2, 2001; 276(10): 7327 - 7336.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xu and Q. Yu
Angiopoietin-1, Unlike Angiopoietin-2, Is Incorporated into the Extracellular Matrix via Its Linker Peptide Region
J. Biol. Chem., September 7, 2001; 276(37): 34990 - 34998.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Cichy and E. Pure
Oncostatin M and Transforming Growth Factor-beta 1 Induce Post-translational Modification and Hyaluronan Binding to CD44 in Lung-derived Epithelial Tumor Cells
J. Biol. Chem., June 9, 2000; 275(24): 18061 - 18069.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.